Latest news
Loading news…
Cidara Therapeutics develops targeted immunotherapies aimed at improving treatment outcomes for patients with serious diseases.
Cidara Therapeutics was acquired by Merck in 2025 for $9B.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
84
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Company Info
- Org types
- company
- HQ
- San Diego, California, United States
Key People at Cidara Therapeutics
CEO & President
EVP, Technical Operations
Chief Financial Officer & Chief Business Officer
Chief Operating Officer
Chief Development Officer
CBO
84
professional contacts at Cidara Therapeutics
Contact execs at Cidara Therapeutics →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Cidara Therapeutics
Loading news…
FAQs about Cidara Therapeutics
People who checked this page also checked these
Browse the full Acquirezy directory.